nodes	percent_of_prediction	percent_of_DWPC	metapath
Miconazole—NOS2—psoriatic arthritis	0.527	1	CbGaD
Miconazole—NOS2—Dexamethasone—psoriatic arthritis	0.126	0.296	CbGbCtD
Miconazole—CYP17A1—Dexamethasone—psoriatic arthritis	0.0625	0.147	CbGbCtD
Miconazole—CYP19A1—Betamethasone—psoriatic arthritis	0.0418	0.0985	CbGbCtD
Miconazole—CYP2A6—Prednisolone—psoriatic arthritis	0.0262	0.0616	CbGbCtD
Miconazole—CYP19A1—Dexamethasone—psoriatic arthritis	0.0243	0.0573	CbGbCtD
Miconazole—CYP2A6—Dexamethasone—psoriatic arthritis	0.0154	0.0363	CbGbCtD
Miconazole—ABCB1—Methylprednisolone—psoriatic arthritis	0.0136	0.032	CbGbCtD
Miconazole—CYP2C19—Prednisone—psoriatic arthritis	0.0102	0.0241	CbGbCtD
Miconazole—CYP2E1—Dexamethasone—psoriatic arthritis	0.0102	0.024	CbGbCtD
Miconazole—CYP2B6—Dexamethasone—psoriatic arthritis	0.01	0.0236	CbGbCtD
Miconazole—ABCB1—Betamethasone—psoriatic arthritis	0.00885	0.0208	CbGbCtD
Miconazole—ABCB1—Prednisolone—psoriatic arthritis	0.00873	0.0206	CbGbCtD
Miconazole—ABCB1—Prednisone—psoriatic arthritis	0.00824	0.0194	CbGbCtD
Miconazole—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00815	0.0192	CbGbCtD
Miconazole—CYP2C19—Dexamethasone—psoriatic arthritis	0.00638	0.015	CbGbCtD
Miconazole—CYP3A4—Triamcinolone—psoriatic arthritis	0.00618	0.0145	CbGbCtD
Miconazole—CYP2C9—Dexamethasone—psoriatic arthritis	0.0053	0.0125	CbGbCtD
Miconazole—CYP3A4—Betamethasone—psoriatic arthritis	0.0053	0.0125	CbGbCtD
Miconazole—CYP3A4—Prednisolone—psoriatic arthritis	0.00523	0.0123	CbGbCtD
Miconazole—ABCB1—Dexamethasone—psoriatic arthritis	0.00515	0.0121	CbGbCtD
Miconazole—CYP3A4—Prednisone—psoriatic arthritis	0.00494	0.0116	CbGbCtD
Miconazole—CYP2D6—Dexamethasone—psoriatic arthritis	0.00485	0.0114	CbGbCtD
Miconazole—ABCB1—Methotrexate—psoriatic arthritis	0.00414	0.00974	CbGbCtD
Miconazole—CYP3A4—Dexamethasone—psoriatic arthritis	0.00308	0.00726	CbGbCtD
Miconazole—NOS2—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.00162	0.0847	CbGpPWpGaD
Miconazole—NOS2—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.00138	0.0721	CbGpPWpGaD
Miconazole—KCNMB2—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.00129	0.0675	CbGpPWpGaD
Miconazole—KCNMB3—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.00129	0.0675	CbGpPWpGaD
Miconazole—KCNMB1—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.00129	0.0675	CbGpPWpGaD
Miconazole—KCNMB4—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.00129	0.0675	CbGpPWpGaD
Miconazole—Allergic contact dermatitis—Triamcinolone—psoriatic arthritis	0.00103	0.035	CcSEcCtD
Miconazole—NOS2—ATF-2 transcription factor network—IL23A—psoriatic arthritis	0.000948	0.0496	CbGpPWpGaD
Miconazole—Allergic contact dermatitis—Betamethasone—psoriatic arthritis	0.00093	0.0318	CcSEcCtD
Miconazole—Allergic contact dermatitis—Dexamethasone—psoriatic arthritis	0.00093	0.0318	CcSEcCtD
Miconazole—NOS3—Effects of Nitric Oxide—NOS2—psoriatic arthritis	0.000888	0.0465	CbGpPWpGaD
Miconazole—NOS3—ACE Inhibitor Pathway—ACE—psoriatic arthritis	0.000839	0.0439	CbGpPWpGaD
Miconazole—Neutropenia—Auranofin—psoriatic arthritis	0.000717	0.0245	CcSEcCtD
Miconazole—Stomatitis—Auranofin—psoriatic arthritis	0.000666	0.0227	CcSEcCtD
Miconazole—NOS2—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.000644	0.0337	CbGpPWpGaD
Miconazole—NOS2—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.000599	0.0314	CbGpPWpGaD
Miconazole—Lymphopenia—Prednisone—psoriatic arthritis	0.000553	0.0189	CcSEcCtD
Miconazole—Tooth disorder—Triamcinolone—psoriatic arthritis	0.000552	0.0189	CcSEcCtD
Miconazole—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.000532	0.0278	CbGpPWpGaD
Miconazole—Dysgeusia—Auranofin—psoriatic arthritis	0.000523	0.0179	CcSEcCtD
Miconazole—KCNMB2—Platelet homeostasis—NOS2—psoriatic arthritis	0.000502	0.0263	CbGpPWpGaD
Miconazole—KCNMB4—Platelet homeostasis—NOS2—psoriatic arthritis	0.000502	0.0263	CbGpPWpGaD
Miconazole—KCNMB1—Platelet homeostasis—NOS2—psoriatic arthritis	0.000502	0.0263	CbGpPWpGaD
Miconazole—KCNMB3—Platelet homeostasis—NOS2—psoriatic arthritis	0.000502	0.0263	CbGpPWpGaD
Miconazole—Anaemia—Auranofin—psoriatic arthritis	0.000494	0.0169	CcSEcCtD
Miconazole—Angioedema—Auranofin—psoriatic arthritis	0.000488	0.0167	CcSEcCtD
Miconazole—NOS2—Type II interferon signaling (IFNG)—HLA-B—psoriatic arthritis	0.000417	0.0218	CbGpPWpGaD
Miconazole—Anorexia—Auranofin—psoriatic arthritis	0.000416	0.0142	CcSEcCtD
Miconazole—NOS2—IL12-mediated signaling events—IL12B—psoriatic arthritis	0.000407	0.0213	CbGpPWpGaD
Miconazole—Decreased appetite—Auranofin—psoriatic arthritis	0.000379	0.0129	CcSEcCtD
Miconazole—NOS3—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.000369	0.0193	CbGpPWpGaD
Miconazole—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000356	0.0122	CcSEcCtD
Miconazole—Dermatitis contact—Triamcinolone—psoriatic arthritis	0.000354	0.0121	CcSEcCtD
Miconazole—Urticaria—Auranofin—psoriatic arthritis	0.000346	0.0118	CcSEcCtD
Miconazole—Abdominal pain—Auranofin—psoriatic arthritis	0.000345	0.0118	CcSEcCtD
Miconazole—NOS3—Leptin signaling pathway—REL—psoriatic arthritis	0.000338	0.0177	CbGpPWpGaD
Miconazole—Dermatitis contact—Betamethasone—psoriatic arthritis	0.000321	0.011	CcSEcCtD
Miconazole—Dermatitis contact—Dexamethasone—psoriatic arthritis	0.000321	0.011	CcSEcCtD
Miconazole—Pruritus—Auranofin—psoriatic arthritis	0.000308	0.0105	CcSEcCtD
Miconazole—Diarrhoea—Auranofin—psoriatic arthritis	0.000298	0.0102	CcSEcCtD
Miconazole—NOS3—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—psoriatic arthritis	0.000279	0.0146	CbGpPWpGaD
Miconazole—Vomiting—Auranofin—psoriatic arthritis	0.000277	0.00946	CcSEcCtD
Miconazole—Rash—Auranofin—psoriatic arthritis	0.000275	0.00938	CcSEcCtD
Miconazole—Dermatitis—Auranofin—psoriatic arthritis	0.000275	0.00937	CcSEcCtD
Miconazole—Nausea—Auranofin—psoriatic arthritis	0.000259	0.00884	CcSEcCtD
Miconazole—NOS2—IL12-mediated signaling events—HLA-DRB1—psoriatic arthritis	0.00024	0.0125	CbGpPWpGaD
Miconazole—Mouth ulceration—Methotrexate—psoriatic arthritis	0.000214	0.0073	CcSEcCtD
Miconazole—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000209	0.00713	CcSEcCtD
Miconazole—KCNMA1—Platelet homeostasis—NOS2—psoriatic arthritis	0.000207	0.0108	CbGpPWpGaD
Miconazole—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.0002	0.00683	CcSEcCtD
Miconazole—Infestation—Methylprednisolone—psoriatic arthritis	0.0002	0.00683	CcSEcCtD
Miconazole—NOS2—IL23-mediated signaling events—TNF—psoriatic arthritis	0.000167	0.00873	CbGpPWpGaD
Miconazole—Neutropenia—Prednisone—psoriatic arthritis	0.000166	0.00567	CcSEcCtD
Miconazole—NOS3—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000164	0.00859	CbGpPWpGaD
Miconazole—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000162	0.00553	CcSEcCtD
Miconazole—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000162	0.00552	CcSEcCtD
Miconazole—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000158	0.00539	CcSEcCtD
Miconazole—Angioedema—Prednisolone—psoriatic arthritis	0.000156	0.00531	CcSEcCtD
Miconazole—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000155	0.00528	CcSEcCtD
Miconazole—Malaise—Prednisolone—psoriatic arthritis	0.000154	0.00524	CcSEcCtD
Miconazole—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000153	0.00524	CcSEcCtD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000146	0.00765	CbGpPWpGaD
Miconazole—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000145	0.00496	CcSEcCtD
Miconazole—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000145	0.00495	CcSEcCtD
Miconazole—NOS3—Platelet homeostasis—NOS2—psoriatic arthritis	0.000144	0.00752	CbGpPWpGaD
Miconazole—Discomfort—Prednisolone—psoriatic arthritis	0.000143	0.00489	CcSEcCtD
Miconazole—Angioedema—Triamcinolone—psoriatic arthritis	0.000143	0.00488	CcSEcCtD
Miconazole—Angioedema—Methylprednisolone—psoriatic arthritis	0.000143	0.00487	CcSEcCtD
Miconazole—Malaise—Triamcinolone—psoriatic arthritis	0.000141	0.00482	CcSEcCtD
Miconazole—Malaise—Methylprednisolone—psoriatic arthritis	0.000141	0.00481	CcSEcCtD
Miconazole—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000139	0.00474	CcSEcCtD
Miconazole—Neutropenia—Methotrexate—psoriatic arthritis	0.000139	0.00474	CcSEcCtD
Miconazole—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000138	0.00471	CcSEcCtD
Miconazole—Cough—Triamcinolone—psoriatic arthritis	0.000137	0.00467	CcSEcCtD
Miconazole—KCNH7—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000135	0.00708	CbGpPWpGaD
Miconazole—Infestation NOS—Methotrexate—psoriatic arthritis	0.000132	0.00452	CcSEcCtD
Miconazole—Infestation—Methotrexate—psoriatic arthritis	0.000132	0.00452	CcSEcCtD
Miconazole—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000132	0.0045	CcSEcCtD
Miconazole—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000132	0.0045	CcSEcCtD
Miconazole—Discomfort—Triamcinolone—psoriatic arthritis	0.000132	0.0045	CcSEcCtD
Miconazole—Discomfort—Methylprednisolone—psoriatic arthritis	0.000131	0.00449	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000131	0.00448	CcSEcCtD
Miconazole—Dry mouth—Triamcinolone—psoriatic arthritis	0.00013	0.00445	CcSEcCtD
Miconazole—Angioedema—Dexamethasone—psoriatic arthritis	0.00013	0.00443	CcSEcCtD
Miconazole—Angioedema—Betamethasone—psoriatic arthritis	0.00013	0.00443	CcSEcCtD
Miconazole—Stomatitis—Methotrexate—psoriatic arthritis	0.000129	0.0044	CcSEcCtD
Miconazole—Immune system disorder—Prednisone—psoriatic arthritis	0.000128	0.00438	CcSEcCtD
Miconazole—Malaise—Dexamethasone—psoriatic arthritis	0.000128	0.00437	CcSEcCtD
Miconazole—Malaise—Betamethasone—psoriatic arthritis	0.000128	0.00437	CcSEcCtD
Miconazole—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000128	0.00436	CcSEcCtD
Miconazole—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000128	0.00435	CcSEcCtD
Miconazole—Infection—Triamcinolone—psoriatic arthritis	0.000127	0.00433	CcSEcCtD
Miconazole—Infection—Methylprednisolone—psoriatic arthritis	0.000127	0.00432	CcSEcCtD
Miconazole—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000125	0.00427	CcSEcCtD
Miconazole—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000125	0.00427	CcSEcCtD
Miconazole—Discomfort—Dexamethasone—psoriatic arthritis	0.00012	0.00408	CcSEcCtD
Miconazole—Discomfort—Betamethasone—psoriatic arthritis	0.00012	0.00408	CcSEcCtD
Miconazole—Pain—Prednisolone—psoriatic arthritis	0.000119	0.00406	CcSEcCtD
Miconazole—Hepatitis—Methotrexate—psoriatic arthritis	0.000119	0.00406	CcSEcCtD
Miconazole—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000116	0.00396	CcSEcCtD
Miconazole—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000116	0.00396	CcSEcCtD
Miconazole—Infection—Dexamethasone—psoriatic arthritis	0.000115	0.00393	CcSEcCtD
Miconazole—Infection—Betamethasone—psoriatic arthritis	0.000115	0.00393	CcSEcCtD
Miconazole—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000115	0.00392	CcSEcCtD
Miconazole—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000115	0.00391	CcSEcCtD
Miconazole—Anaemia—Prednisone—psoriatic arthritis	0.000114	0.0039	CcSEcCtD
Miconazole—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000114	0.00388	CcSEcCtD
Miconazole—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000114	0.00388	CcSEcCtD
Miconazole—Angioedema—Prednisone—psoriatic arthritis	0.000113	0.00386	CcSEcCtD
Miconazole—KCNMB2—Hemostasis—NOS2—psoriatic arthritis	0.000112	0.00589	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—NOS2—psoriatic arthritis	0.000112	0.00589	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—NOS2—psoriatic arthritis	0.000112	0.00589	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—NOS2—psoriatic arthritis	0.000112	0.00589	CbGpPWpGaD
Miconazole—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000112	0.00383	CcSEcCtD
Miconazole—Malaise—Prednisone—psoriatic arthritis	0.000112	0.00381	CcSEcCtD
Miconazole—Anorexia—Dexamethasone—psoriatic arthritis	0.000111	0.00377	CcSEcCtD
Miconazole—Anorexia—Betamethasone—psoriatic arthritis	0.000111	0.00377	CcSEcCtD
Miconazole—Urticaria—Prednisolone—psoriatic arthritis	0.00011	0.00377	CcSEcCtD
Miconazole—Fatigue—Triamcinolone—psoriatic arthritis	0.00011	0.00376	CcSEcCtD
Miconazole—Fatigue—Methylprednisolone—psoriatic arthritis	0.00011	0.00375	CcSEcCtD
Miconazole—Pain—Triamcinolone—psoriatic arthritis	0.000109	0.00373	CcSEcCtD
Miconazole—Immune system disorder—Methotrexate—psoriatic arthritis	0.000107	0.00366	CcSEcCtD
Miconazole—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000107	0.00366	CcSEcCtD
Miconazole—Chills—Methotrexate—psoriatic arthritis	0.000107	0.00364	CcSEcCtD
Miconazole—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000105	0.0036	CcSEcCtD
Miconazole—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000105	0.00359	CcSEcCtD
Miconazole—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000104	0.00356	CcSEcCtD
Miconazole—Discomfort—Prednisone—psoriatic arthritis	0.000104	0.00355	CcSEcCtD
Miconazole—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000102	0.0035	CcSEcCtD
Miconazole—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000102	0.00533	CbGpPWpGaD
Miconazole—Urticaria—Triamcinolone—psoriatic arthritis	0.000102	0.00347	CcSEcCtD
Miconazole—Urticaria—Methylprednisolone—psoriatic arthritis	0.000101	0.00346	CcSEcCtD
Miconazole—Dysgeusia—Methotrexate—psoriatic arthritis	0.000101	0.00346	CcSEcCtD
Miconazole—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000101	0.00345	CcSEcCtD
Miconazole—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000101	0.00344	CcSEcCtD
Miconazole—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000101	0.00344	CcSEcCtD
Miconazole—Decreased appetite—Betamethasone—psoriatic arthritis	0.000101	0.00344	CcSEcCtD
Miconazole—Infection—Prednisone—psoriatic arthritis	0.0001	0.00343	CcSEcCtD
Miconazole—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0001	0.00342	CcSEcCtD
Miconazole—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0001	0.00342	CcSEcCtD
Miconazole—Fatigue—Betamethasone—psoriatic arthritis	0.0001	0.00341	CcSEcCtD
Miconazole—Fatigue—Dexamethasone—psoriatic arthritis	0.0001	0.00341	CcSEcCtD
Miconazole—Pain—Betamethasone—psoriatic arthritis	9.92e-05	0.00339	CcSEcCtD
Miconazole—Pain—Dexamethasone—psoriatic arthritis	9.92e-05	0.00339	CcSEcCtD
Miconazole—Nervous system disorder—Prednisone—psoriatic arthritis	9.9e-05	0.00338	CcSEcCtD
Miconazole—KCNMA1—Circadian rythm related genes—NOS2—psoriatic arthritis	9.72e-05	0.00509	CbGpPWpGaD
Miconazole—Anorexia—Prednisone—psoriatic arthritis	9.63e-05	0.00329	CcSEcCtD
Miconazole—Ill-defined disorder—Methotrexate—psoriatic arthritis	9.6e-05	0.00328	CcSEcCtD
Miconazole—Anaemia—Methotrexate—psoriatic arthritis	9.56e-05	0.00326	CcSEcCtD
Miconazole—Feeling abnormal—Dexamethasone—psoriatic arthritis	9.56e-05	0.00326	CcSEcCtD
Miconazole—Feeling abnormal—Betamethasone—psoriatic arthritis	9.56e-05	0.00326	CcSEcCtD
Miconazole—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	9.48e-05	0.00324	CcSEcCtD
Miconazole—Gastrointestinal pain—Betamethasone—psoriatic arthritis	9.48e-05	0.00324	CcSEcCtD
Miconazole—Hypersensitivity—Triamcinolone—psoriatic arthritis	9.42e-05	0.00321	CcSEcCtD
Miconazole—Hypersensitivity—Methylprednisolone—psoriatic arthritis	9.4e-05	0.00321	CcSEcCtD
Miconazole—Malaise—Methotrexate—psoriatic arthritis	9.33e-05	0.00318	CcSEcCtD
Miconazole—Urticaria—Betamethasone—psoriatic arthritis	9.21e-05	0.00315	CcSEcCtD
Miconazole—Urticaria—Dexamethasone—psoriatic arthritis	9.21e-05	0.00315	CcSEcCtD
Miconazole—Asthenia—Triamcinolone—psoriatic arthritis	9.17e-05	0.00313	CcSEcCtD
Miconazole—Abdominal pain—Dexamethasone—psoriatic arthritis	9.17e-05	0.00313	CcSEcCtD
Miconazole—Abdominal pain—Betamethasone—psoriatic arthritis	9.17e-05	0.00313	CcSEcCtD
Miconazole—Asthenia—Methylprednisolone—psoriatic arthritis	9.15e-05	0.00312	CcSEcCtD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	9.04e-05	0.00473	CbGpPWpGaD
Miconazole—Pruritus—Triamcinolone—psoriatic arthritis	9.04e-05	0.00309	CcSEcCtD
Miconazole—Cough—Methotrexate—psoriatic arthritis	9.02e-05	0.00308	CcSEcCtD
Miconazole—Pruritus—Methylprednisolone—psoriatic arthritis	9.02e-05	0.00308	CcSEcCtD
Miconazole—Decreased appetite—Prednisone—psoriatic arthritis	8.78e-05	0.003	CcSEcCtD
Miconazole—Rash—Prednisolone—psoriatic arthritis	8.76e-05	0.00299	CcSEcCtD
Miconazole—Dermatitis—Prednisolone—psoriatic arthritis	8.76e-05	0.00299	CcSEcCtD
Miconazole—Diarrhoea—Methylprednisolone—psoriatic arthritis	8.73e-05	0.00298	CcSEcCtD
Miconazole—Fatigue—Prednisone—psoriatic arthritis	8.71e-05	0.00297	CcSEcCtD
Miconazole—Headache—Prednisolone—psoriatic arthritis	8.71e-05	0.00297	CcSEcCtD
Miconazole—Discomfort—Methotrexate—psoriatic arthritis	8.7e-05	0.00297	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	8.64e-05	0.00453	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	8.59e-05	0.0045	CbGpPWpGaD
Miconazole—Anaphylactic shock—Methotrexate—psoriatic arthritis	8.44e-05	0.00288	CcSEcCtD
Miconazole—Infection—Methotrexate—psoriatic arthritis	8.39e-05	0.00286	CcSEcCtD
Miconazole—Feeling abnormal—Prednisone—psoriatic arthritis	8.32e-05	0.00284	CcSEcCtD
Miconazole—Asthenia—Betamethasone—psoriatic arthritis	8.32e-05	0.00284	CcSEcCtD
Miconazole—Asthenia—Dexamethasone—psoriatic arthritis	8.32e-05	0.00284	CcSEcCtD
Miconazole—Nervous system disorder—Methotrexate—psoriatic arthritis	8.28e-05	0.00283	CcSEcCtD
Miconazole—Gastrointestinal pain—Prednisone—psoriatic arthritis	8.26e-05	0.00282	CcSEcCtD
Miconazole—Nausea—Prednisolone—psoriatic arthritis	8.26e-05	0.00282	CcSEcCtD
Miconazole—Pruritus—Betamethasone—psoriatic arthritis	8.2e-05	0.0028	CcSEcCtD
Miconazole—Pruritus—Dexamethasone—psoriatic arthritis	8.2e-05	0.0028	CcSEcCtD
Miconazole—Vomiting—Triamcinolone—psoriatic arthritis	8.13e-05	0.00277	CcSEcCtD
Miconazole—Vomiting—Methylprednisolone—psoriatic arthritis	8.11e-05	0.00277	CcSEcCtD
Miconazole—Rash—Triamcinolone—psoriatic arthritis	8.06e-05	0.00275	CcSEcCtD
Miconazole—Dermatitis—Triamcinolone—psoriatic arthritis	8.05e-05	0.00275	CcSEcCtD
Miconazole—Anorexia—Methotrexate—psoriatic arthritis	8.05e-05	0.00275	CcSEcCtD
Miconazole—Rash—Methylprednisolone—psoriatic arthritis	8.04e-05	0.00274	CcSEcCtD
Miconazole—Dermatitis—Methylprednisolone—psoriatic arthritis	8.03e-05	0.00274	CcSEcCtD
Miconazole—Urticaria—Prednisone—psoriatic arthritis	8.02e-05	0.00274	CcSEcCtD
Miconazole—Headache—Triamcinolone—psoriatic arthritis	8.01e-05	0.00273	CcSEcCtD
Miconazole—Headache—Methylprednisolone—psoriatic arthritis	7.99e-05	0.00273	CcSEcCtD
Miconazole—Abdominal pain—Prednisone—psoriatic arthritis	7.98e-05	0.00273	CcSEcCtD
Miconazole—Diarrhoea—Betamethasone—psoriatic arthritis	7.93e-05	0.00271	CcSEcCtD
Miconazole—Diarrhoea—Dexamethasone—psoriatic arthritis	7.93e-05	0.00271	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	7.91e-05	0.00414	CbGpPWpGaD
Miconazole—Nausea—Triamcinolone—psoriatic arthritis	7.59e-05	0.00259	CcSEcCtD
Miconazole—Nausea—Methylprednisolone—psoriatic arthritis	7.58e-05	0.00259	CcSEcCtD
Miconazole—Hypersensitivity—Prednisone—psoriatic arthritis	7.44e-05	0.00254	CcSEcCtD
Miconazole—Vomiting—Betamethasone—psoriatic arthritis	7.37e-05	0.00252	CcSEcCtD
Miconazole—Vomiting—Dexamethasone—psoriatic arthritis	7.37e-05	0.00252	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	7.35e-05	0.00385	CbGpPWpGaD
Miconazole—Decreased appetite—Methotrexate—psoriatic arthritis	7.34e-05	0.0025	CcSEcCtD
Miconazole—Rash—Betamethasone—psoriatic arthritis	7.31e-05	0.0025	CcSEcCtD
Miconazole—Rash—Dexamethasone—psoriatic arthritis	7.31e-05	0.0025	CcSEcCtD
Miconazole—Dermatitis—Dexamethasone—psoriatic arthritis	7.31e-05	0.00249	CcSEcCtD
Miconazole—Dermatitis—Betamethasone—psoriatic arthritis	7.31e-05	0.00249	CcSEcCtD
Miconazole—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	7.29e-05	0.00249	CcSEcCtD
Miconazole—Fatigue—Methotrexate—psoriatic arthritis	7.28e-05	0.00248	CcSEcCtD
Miconazole—Headache—Dexamethasone—psoriatic arthritis	7.27e-05	0.00248	CcSEcCtD
Miconazole—Headache—Betamethasone—psoriatic arthritis	7.27e-05	0.00248	CcSEcCtD
Miconazole—Asthenia—Prednisone—psoriatic arthritis	7.25e-05	0.00247	CcSEcCtD
Miconazole—Pain—Methotrexate—psoriatic arthritis	7.22e-05	0.00246	CcSEcCtD
Miconazole—Pruritus—Prednisone—psoriatic arthritis	7.15e-05	0.00244	CcSEcCtD
Miconazole—Feeling abnormal—Methotrexate—psoriatic arthritis	6.96e-05	0.00237	CcSEcCtD
Miconazole—Diarrhoea—Prednisone—psoriatic arthritis	6.91e-05	0.00236	CcSEcCtD
Miconazole—Gastrointestinal pain—Methotrexate—psoriatic arthritis	6.9e-05	0.00236	CcSEcCtD
Miconazole—Nausea—Betamethasone—psoriatic arthritis	6.89e-05	0.00235	CcSEcCtD
Miconazole—Nausea—Dexamethasone—psoriatic arthritis	6.89e-05	0.00235	CcSEcCtD
Miconazole—Urticaria—Methotrexate—psoriatic arthritis	6.71e-05	0.00229	CcSEcCtD
Miconazole—Abdominal pain—Methotrexate—psoriatic arthritis	6.67e-05	0.00228	CcSEcCtD
Miconazole—NOS2—Spinal Cord Injury—TNF—psoriatic arthritis	6.59e-05	0.00345	CbGpPWpGaD
Miconazole—Vomiting—Prednisone—psoriatic arthritis	6.42e-05	0.00219	CcSEcCtD
Miconazole—Rash—Prednisone—psoriatic arthritis	6.37e-05	0.00217	CcSEcCtD
Miconazole—Dermatitis—Prednisone—psoriatic arthritis	6.36e-05	0.00217	CcSEcCtD
Miconazole—Headache—Prednisone—psoriatic arthritis	6.33e-05	0.00216	CcSEcCtD
Miconazole—Hypersensitivity—Methotrexate—psoriatic arthritis	6.22e-05	0.00212	CcSEcCtD
Miconazole—Asthenia—Methotrexate—psoriatic arthritis	6.06e-05	0.00207	CcSEcCtD
Miconazole—Nausea—Prednisone—psoriatic arthritis	6e-05	0.00205	CcSEcCtD
Miconazole—Pruritus—Methotrexate—psoriatic arthritis	5.97e-05	0.00204	CcSEcCtD
Miconazole—Diarrhoea—Methotrexate—psoriatic arthritis	5.78e-05	0.00197	CcSEcCtD
Miconazole—Vomiting—Methotrexate—psoriatic arthritis	5.37e-05	0.00183	CcSEcCtD
Miconazole—Rash—Methotrexate—psoriatic arthritis	5.32e-05	0.00182	CcSEcCtD
Miconazole—Dermatitis—Methotrexate—psoriatic arthritis	5.32e-05	0.00182	CcSEcCtD
Miconazole—Headache—Methotrexate—psoriatic arthritis	5.29e-05	0.00181	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	5.11e-05	0.00268	CbGpPWpGaD
Miconazole—Nausea—Methotrexate—psoriatic arthritis	5.01e-05	0.00171	CcSEcCtD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	4.76e-05	0.00249	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—NOS2—psoriatic arthritis	4.64e-05	0.00243	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	4.33e-05	0.00227	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	3.48e-05	0.00182	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—NOS2—psoriatic arthritis	3.22e-05	0.00168	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	2.52e-05	0.00132	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	2.52e-05	0.00132	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	2.05e-05	0.00107	CbGpPWpGaD
Miconazole—NOS3—Disease—NOS2—psoriatic arthritis	1.56e-05	0.000815	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.01e-05	0.000528	CbGpPWpGaD
